BIOS health is partnering with Canadian universities to develop an artificial intelligence closed-loop neuromodulation system for chronic cardiac conditions.
CORDIS reports two US based biotech companies have been granted ethical permission to attempt to regenerate the brains of people declared clinically dead from TBI.
Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).
Today the Governor’s Office of Business and Economic Development (GO-Biz) announced the formation of a new Cyber-Health Information Technology Advisory Board as part of an ongoing effort to support cybersecurity innovation and bolster advanced technology industries.
Weill Neurohub announces a long-term research partnership with Genentech and Roche Holding AG to advance the development of new therapeutics for debilitating brain and central nervous system diseases.